Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Mar 30;322(Pt B):258-268.
doi: 10.1016/j.bbr.2016.06.053. Epub 2016 Jun 28.

A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat

Affiliations
Comparative Study

A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat

B Blair Braden et al. Behav Brain Res. .

Abstract

Introduction: For decades, progestins have been included in hormone therapies (HT) prescribed to women to offset the risk of unopposed estrogen-induced endometrial hyperplasia. However, the potential effects on cognition of subcategories of clinically used progestins have been largely unexplored.

Methods: In two studies, the present investigation evaluated the cognitive effects of norethindrone acetate (NETA), levonorgestrel (LEVO), and medroxyprogesterone acetate (MPA) on the water radial-arm maze (WRAM) and Morris water maze (MM) in middle-aged ovariectomized rats.

Results: In Study 1, six-weeks of a high-dose NETA treatment impaired learning and delayed retention on the WRAM, and impaired reference memory on the MM. Low-dose NETA treatment impaired delayed retention on the WRAM. In Study 2, high-dose NETA treatment was reduced to four-weeks and compared to MPA and LEVO. As previously shown, MPA impaired working memory performance during the lattermost portion of testing, at the highest working memory load, impaired delayed retention on the WRAM, and impaired reference memory on the MM. NETA also impaired performance on these WRAM and MM measures. Interestingly, LEVO did not impair performance, but instead enhanced learning on the WRAM.

Conclusions: The current study corroborates previous evidence that the most commonly prescribed FDA-approved progestin for HT, MPA, impairs learning and memory in the ovariectomized middle-aged rat. When progestins from two different additional subcategories were investigated, NETA impaired learning and memory similarly to MPA, but LEVO enhanced learning. Future research is warranted to determine LEVO's potential as an ideal progestin for optimal health in women, including for cognition.

Keywords: Aging; Cognition; Hormone therapy; Memory; Menopause; Progestin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of progesterone-resembling progestogens: (a) progesterone (b) medroxyprogesterone acetate (MPA), and testosterone-resembling progestins: (c) norethindrone acetate (NETA) (d) levonorgesterel (LEVO). Timeline for (e) Study 1 and (f) Study 2 summarizing duration of treatment and behavior testing.
Figure 2
Figure 2
Study 1 Mean error scores (+SE) collapsed across all trials on the water radial-arm maze during the learning (Days 2–6) and asymptotic (Days 7–12) testing phases: (a) Working Memory Correct errors, (b) Working Memory Incorrect errors, and (c) Reference Memory errors. (d) Mean Working Memory Correct error scores (+SE) for baseline (last day of regular testing trial 3) vs. delay (trial 3 immediately following a 6 hour delay). *p < 0.05; ^p < 0.05 Baseline vs. Delay
Figure 3
Figure 3
Study 1 Morris maze mean (+SE) (a) Distance scores in centimeters and (b) Latency scores in seconds across all days of testing (Days 1–3). (c) Mean percent Distance in the target NE quadrant as compared to the opposite SW quadrant during the probe trial. *p <.05; #p <.10; ***p <.0001 NE quadrant vs. SW quadrant
Figure 4
Figure 4
Study 2 (a) Mean error scores (+SE) collapsed across all trials on the water radial-arm maze during the learning (Days 2–6) and asymptotic (Days 7–14) testing phases for Working Memory Incorrect errors. Working memory load effect during the learning testing phase (Days 2–6) for (b) Working Memory Correct errors and (c) Working Memory Incorrect errors, and (d) during the last day of regular testing (Day 14) for Working Memory Correct errors. (e) Mean Working Memory Correct error scores (+SE) for baseline (last day of regular testing trial 3) vs. delay (trial 3 immediately following a 4 hour delay). *p ≤ 0.05; #p <.10; ^p < 0.05 Baseline vs. Delay
Figure 5
Figure 5
Study 2 Morris maze mean (+SE) (a) Distance scores in centimeters and (b) Latency scores in seconds across all days of testing (Days 1–3). (c) Mean percent Distance in the target NE quadrant as compared to the opposite SW quadrant during the probe trial. *p < 0.05; #p <.10; ***p < 0.001 NE quadrant vs. SW quadrant

Similar articles

Cited by

References

    1. Sitruk-Ware R. Hormonal replacement therapy. Rev Endocr Metab Disord. 2002;3(3):243–56. - PubMed
    1. Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975;293(23):1164–7. - PubMed
    1. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975;293(23):1167–70. - PubMed
    1. Sood R, Shuster L, Smith R, Vincent A, Jatoi A. Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians. J Am Board Fam Med. 2011;24(2):202–10. - PMC - PubMed
    1. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–62. - PubMed

Publication types

MeSH terms